Ovarian steroids and selective estrogen receptor modulators activity on rat brain NMDA and AMPA receptors

Brain Research Reviews

Volumn 37, Issue 1-3, 2001, Pages 153-161

  Cyr, Michel ^a   Ghribi, Othman ^a   Thibault, Caroline ^a   Morissette, Marc ^a   Landry, Michelle ^a   Di Paolo, Therese ^a  

^a UNIVERSITÉ LAVAL   (Canada)

Author keywords

AMPA; Estradiol; NMPA; Raloxifene; Tamoxifen

Indexed keywords

AMPA RECEPTOR; ESTRADIOL; ESTROGEN RECEPTOR; LIGAND; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PROGESTERONE; RALOXIFENE; RECEPTOR SUBUNIT; TAMOXIFEN;

BRAIN REGION; CONFERENCE PAPER; DRUG EFFECT; ESTROGEN ACTIVITY; IN SITU HYBRIDIZATION; NEUROMODULATION; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; RECEPTOR BINDING; TISSUE DISTRIBUTION;

ANIMALS; BRAIN; FEMALE; OVARY; RATS; RECEPTORS, AMPA; RECEPTORS, ESTROGEN; RECEPTORS, N-METHYL-D-ASPARTATE; STEROIDS;

EID: 0035660125     PISSN: 01650173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0173(01)00115-1     Document Type: Conference Paper

References (41)

1. Opposite modulatory effects of ovarian hormones on rat brain dopamine and serotonin transporters
2. Functional analysis of the proximal 5′-flanking region of the N-methyl-D-aspartate receptor subunit gene, NMDAR1
3. Single-stranded DNA-binding proteins and neuron-restrictive silencer factor participate in cell-specific transcriptional control of the NMDAR1 gene
4. Rapid effects of estrogen or progesterone on the amphetamine-induced increase in striatal dopamine are enhanced by estrogen priming: A microdialysis study
5. A synaptic model of memory: Long-term potentiation in the hippocampus
6. Regulation of GluR2 promoter activity by neurotrophic factors via a neuron-restrictive silencer element
7. Native N-methyl-D-aspartate receptors containing NR2A and NR2B subunits have pharmacologically distinct competitive antagonist binding sites
8. Selective estrogen receptor modulators: Clinical spectrum
9. Drugs with estrogen-like potency and brain activity: Potential therapeutic application for the CNS
10. Regional and selective effects of estradiol and progesterone on NMDA and AMPA receptors in the rat brain
11. Modulation by estrogen-receptor directed drugs of 5-hydroxytryptamine-2A receptors in rat brain
12. Estrogenic activity of tamoxifen and raloxifene on rat brain AMPA receptors
13. Estogen-like activity of tamoxifen and raloxifene on NMDA receptor binding and expression of its subunits in rat brain
14. Acethylcholine mediates the estrogen-induced increase in hippocampal NMDA receptor binding and the associated enhancement in working memory performance
15. Gonadal steroids target AMPA glutamate receptor-containing neurons in the rat hypothalamus, septum and amygdala: A morphological and biochemical study
16. The glutamate receptor ion channels
17. Modulation of brain dopamine transmission by sex steroids
18. Progesterone enhances l-dopa-stimulated dopamine release from the caudate nucleus of freely behaving ovariectomized-estrogen-primed rats
19. Prospects for new restorative and neuroprotective treatments in Parkinson's disease
20. Time-course of the effects of ovarian steroids on the activity of limbic and striatal dopaminergic neurons in female rat brain
21. Differential regulation of NMDAR1 mRNA and protein by estradiol in the rat hippocampus
22. Effect of estrogen and progesterone on L-dopa induced dyskinesia in MPTP-treated monkeys
23. Selective estrogen receptor modulators (SERMs)
24. Hormonal regulation of glutamate receptor gene expression in the anteroventral periventricular nucleus of the hypothalamus
25. Time-dependent effects of ovarian steroids on tyrosine hydroxylase activity in the limbic forebrain of female rats
26. Estrogen, cognition, and a woman's risk of Alzheimer's disease
27. Tripartite steroid hormone receptor pharmacology: Interaction with multiple effector sites as a basis for the cell- and promoter-specific action of these hormones
28. Cloning and characterization of promoter and 5′-UTR of the NMDA receptor subunit epsilon 2: Evidence for alternative splicing of 5′-non-coding exon
29. Expression and neuropeptidergic characterization of estrogen receptors (ERalpha and ERbeta) throughout the rat brain: Anatomical evidence of distinct roles of each subtype
30. Selective oestrogen receptor modulation: Molecular pharmacology for the millennium
31. Regionally different N-methyl-d-aspartate receptors distinguished by ligand binding and quantitative autoradiography of [3H]-CGP 39653 in rat brain
32. 3H]Ro 25-6981, a potent and selective antagonist of NMDA receptors containing NR2B subunits
33. Transcriptional regulation of the GluR2 gene: Neural-specific expression, multiple promoters, and regulatory elements
34. Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites
35. The potential role for estrogen replacement therapy in the treatment of the cognitive decline and neurodegeneration associated with Alzheimer's disease
36. Gene structure of the murine N-methyl-d-aspartate receptor subunit NR2C
37. Glutamatergic aspects of schizophrenia
38. Sex steroids and the development of the newborn mouse hypothalamus and preoptic area in vitro: III. Effects of estrogen on dendritic differentiation
39. Estradiol selectively regulates agonist binding sites on the N-methyl-d-aspartate receptor complex in the CA1 region of the hippocampus
40. Effects of oestradiol on hippocampal circuitry
41. Estradiol increases the sensitivity of hippocampal CA1 pyramidal cells to NMDA receptor-mediated synaptic input: Correlation with dendritic spine density